Mycophenolate mofetil (MMF) reduces the pool of dividing and activated CD4+Tcells contributing to control virus load. A single supervised treatment interruption coupled with MMF might highly reduce the overall need of ART

Single supervised treatment interruption coupled with mycophenolate mofetil therapy induces control of HIV-1 RNA replication in patients treated with ART since primary HIV-1 Infection / Ciuffedra, D.; Rizzardi, G. P.; Tassan Din, C.; Travi, G.; Guaraldi, Giovanni; Lazzarin, A.; Pantaleo, G.; Tambussi, G.. - STAMPA. - not applicable:(2005), pp. 239 (n 514)-239. (Intervento presentato al convegno 12th Conference on Retroviruses and Opportunistic Infections tenutosi a Boston, MA-US nel 22-25 Feb 2005).

Single supervised treatment interruption coupled with mycophenolate mofetil therapy induces control of HIV-1 RNA replication in patients treated with ART since primary HIV-1 Infection

GUARALDI, Giovanni;
2005

Abstract

Mycophenolate mofetil (MMF) reduces the pool of dividing and activated CD4+Tcells contributing to control virus load. A single supervised treatment interruption coupled with MMF might highly reduce the overall need of ART
2005
12th Conference on Retroviruses and Opportunistic Infections
Boston, MA-US
22-25 Feb 2005
Ciuffedra, D.; Rizzardi, G. P.; Tassan Din, C.; Travi, G.; Guaraldi, Giovanni; Lazzarin, A.; Pantaleo, G.; Tambussi, G.
Single supervised treatment interruption coupled with mycophenolate mofetil therapy induces control of HIV-1 RNA replication in patients treated with ART since primary HIV-1 Infection / Ciuffedra, D.; Rizzardi, G. P.; Tassan Din, C.; Travi, G.; Guaraldi, Giovanni; Lazzarin, A.; Pantaleo, G.; Tambussi, G.. - STAMPA. - not applicable:(2005), pp. 239 (n 514)-239. (Intervento presentato al convegno 12th Conference on Retroviruses and Opportunistic Infections tenutosi a Boston, MA-US nel 22-25 Feb 2005).
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/593986
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact